Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7535209

O=C(O)C(F)(F)F.O=c1c2cc(F)c(N3CC4CCCNC4C3)cc2n(C2CC2)c(=O)n1O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.42
HSD17B10 Q99714 4/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 3/20 0.35
CYP1A2 P05177 1/20 0.35
TOP2A P11388 1/20 0.35
CYP2C9 P11712 1/20 0.35
TOP2B Q02880 1/20 0.35
TOP1 P11387 2/20 0.32
HRH4 Q9H3N8 2/20 0.32
USP25 Q9UHP3 4/20 0.31
HTR3A P46098 1/20 0.31
MAPT P10636 1/20 0.31
DPP4 P27487 1/20 0.31
PRKD3 O94806 1/20 0.31
PIM1 P11309 1/20 0.31
GSK3A P49840 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6802003 0.94 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL6805232 0.94 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL7010855 0.84 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL7535211 0.84 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL6797651 0.74 PRKD3 (0.42) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL6802382 0.74 LMNA (0.42) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5021675 0.74 KDM4E (0.67) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL6215994 0.74 KDM4E (0.67) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL8982725 0.74 KDM4E (0.67) KDM4EALDH1A1HPGDHSD17B10MEN1
Hydrochloric Acid SCHEMBL8741055 0.73 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents DOMAGALA JOHN MICHAEL (US) 2002-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115674-A1 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents NQO2, TOP1, TOP2A KDM4E 2528/4885ALDH1A1 3064/4885HPGD 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.